2m 2m 2m 2m 2m 2m 2m
GINKGO BIO-A (DNA)
NYSE
$12.35-$0.15 (-1.20%)
Price as of Oct 02, 2026 5:54 PM EDT- $692.3MMarket Cap
- -21.73%1-Year Change
- BiotechnologyIndustry
GINKGO BIO-A (DNA)
$12.35-$0.15 (-1.20%)
DNA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.50 | ||
Change | -$0.33 (-2.57%) | ||
Open | $12.60 | ||
High | $13.16 | ||
Low | $12.11 | ||
Previous Close | $12.83 | ||
Volume | 2,911,318 | ||
30-Day Average Volume | 1,950,732 | ||
1-Week Change | 21.95% | ||
1-Month Change | 80.38% | ||
1-Year Change | -21.73% | ||
3-Year Change | -82.73% | ||
5-Year Change | -97.28% | ||
Fundamentals | |||
Shares Outstanding | 55.4M | ||
Total Assets | $990.0M | ||
Market Cap | $692.3M | ||
Enterprise Value | $607.8M | ||
Period: QTR TTM FY | |||
Revenue | $20.2M | ||
Net Income | -$46.7M | ||
Free Cash Flow | -$46.9M | ||
EBIT | -$46.6M | ||
EBITDA | -$34.3M | ||
Net Working Capital | $259.8M | ||
EPS | -$0.75 | ||
Enterprise Value/EBITDA | -18 | ||
Enterprise Value/Revenue | 30 | ||
P/B | 2 | ||
P/E | -17 | ||
PEG | -0 | ||
Price/Free Cash Flow | -15 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 40 | ||
Last Split Date | 08/20/2024 | ||
Earnings & Revenue